The Permissible Indications Determination requires certain label statements, depending on the potential risk associated with the use of a specific indication. Label statements are being brought into line with the language being used in the new advertising code moving from ‘seek advice’ to ‘talk to’. Generally speaking, these terms would be considered interchangeable, so current products using these indications will not be required to change their medicine labels immediately, but may updated at the next print run.
Table 7. Examples of symptoms statements in the Permissible Indications Determination
|Label statement||When required|
|If symptoms persist, talk to|